Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.

Bergua JM, Montesinos P, Martinez-Cuadrón D, Fernández-Abellán P, Serrano J, Sayas MJ, Prieto-Fernandez J, García R, García-Huerta AJ, Barrios M, Benavente C, Pérez-Encinas M, Simiele A, Rodríguez-Macias G, Herrera-Puente P, Rodríguez-Veiga R, Martínez-Sánchez MP, Amador-Barciela ML, Riaza-Grau R, Sanz MA; PETHEMA group.

Br J Haematol. 2016 Sep;174(5):700-10. doi: 10.1111/bjh.14107. Epub 2016 Apr 26.

PMID:
27118319
2.

Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia.

Vidriales MB, Pérez-López E, Pegenaute C, Castellanos M, Pérez JJ, Chandía M, Díaz-Mediavilla J, Rayón C, de Las Heras N, Fernández-Abellán P, Cabezudo M, de Coca AG, Alonso JM, Olivier C, Hernández-Rivas JM, Montesinos P, Fernández R, García-Suárez J, García M, Sayas MJ, Paiva B, González M, Orfao A, San Miguel JF; PETHEMA Programa para el Estudio de la Terapéutica en Hemopatías Malignas Cooperative Study Group.

Leuk Res. 2016 Jan;40:1-9. doi: 10.1016/j.leukres.2015.10.002. Epub 2015 Oct 22.

PMID:
26598032
3.

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.

Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, González-Campos J, Fernández-Abellán P, Tormo M, Bethencourt C, Brunet S, Hernández-Rivas JM, Moreno MJ, Sarrà J, Del Potro E, Barba P, Bernal T, Grande C, Grau J, Cervera J, Feliu E; PETHEMA Group, Spanish Society of Hematology.

Cancer. 2014 Dec 15;120(24):3958-64. doi: 10.1002/cncr.28950. Epub 2014 Aug 12.

4.

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.

Ribera JM, Oriol A, Morgades M, Montesinos P, Sarrà J, González-Campos J, Brunet S, Tormo M, Fernández-Abellán P, Guàrdia R, Bernal MT, Esteve J, Barba P, Moreno MJ, Bermúdez A, Cladera A, Escoda L, García-Boyero R, Del Potro E, Bergua J, Amigo ML, Grande C, Rabuñal MJ, Hernández-Rivas JM, Feliu E.

J Clin Oncol. 2014 May 20;32(15):1595-604. doi: 10.1200/JCO.2013.52.2425. Epub 2014 Apr 21.

PMID:
24752047
5.

Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.

Ribera JM, García O, Fernández-Abellán P, Lavilla E, Bernal MT, González-Campos J, Brunet S, Monteserín MC, Montesinos P, Sarrá J, Calbacho M, Alvarez-Larrán A, Tormo M, Oriol A; PETHEMA Group.

Br J Haematol. 2012 Nov;159(4):485-8. doi: 10.1111/bjh.12043. Epub 2012 Sep 12. No abstract available.

PMID:
22966847
6.

[Comparison of two initial mobilizing strategies of peripheral blood stem cells for autologous transplantation in patients with lymphoma and human immunodeficiency virus infection].

Sagüés M, Sancho JM, Serrano D, Balsalobre P, Gayoso J, Morgades M, Conde E, Iriondo A, Varela R, Escoda L, Xicoy B, Espigado I, Fernández-Abellán P, Díez JL, Ribera JM.

Med Clin (Barc). 2012 Jul 21;139(5):192-6. doi: 10.1016/j.medcli.2011.05.013. Epub 2011 Jul 31. Spanish.

PMID:
21807388
7.

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

Santamaría CM, Chillón MC, García-Sanz R, Pérez C, Caballero MD, Ramos F, de Coca AG, Alonso JM, Giraldo P, Bernal T, Queizán JA, Rodriguez JN, Fernández-Abellán P, Bárez A, Peñarrubia MJ, Vidriales MB, Balanzategui A, Sarasquete ME, Alcoceba M, Díaz-Mediavilla J, San Miguel JF, Gonzalez M.

Leuk Res. 2009 Dec;33(12):1706-9. doi: 10.1016/j.leukres.2009.04.024. Epub 2009 May 19.

PMID:
19457552
8.

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia.

Santamaría CM, Chillón MC, García-Sanz R, Pérez C, Caballero MD, Ramos F, de Coca AG, Alonso JM, Giraldo P, Bernal T, Queizán JA, Rodriguez JN, Fernández-Abellán P, Bárez A, Peñarrubia MJ, Balanzategui A, Vidriales MB, Sarasquete ME, Alcoceba M, Díaz-Mediavilla J, San Miguel JF, Gonzalez M.

Blood. 2009 Jul 2;114(1):148-52. doi: 10.1182/blood-2008-11-187724. Epub 2009 Apr 27.

9.

Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.

Sancho JM, Morgades M, Arranz R, Fernández-Abellán P, Deben G, Alonso N, Blanes M, Rodríguez MJ, Nicolás C, Sánchez E, Fernández de Sevilla A, Conde E, Ribera JM; QUIT Study (PETHEMA, GELTAMO and GOTEL Groups).

Med Clin (Barc). 2008 Oct 4;131(11):401-5.

PMID:
18928719
10.

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ.

J Clin Oncol. 2008 Apr 10;26(11):1843-9. doi: 10.1200/JCO.2007.13.7265.

PMID:
18398150
11.

Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.

Sancho JM, Deben G, Parker A, Piñana JL, Bolam S, Sánchez-García E, Giménez E, Pascual T, Fernández-Abellán P, Palomera L, Ribera JM.

Int J Hematol. 2007 Jul;86(1):33-6.

PMID:
17675264
12.

Rituximab and autologous stem cell transplantation for malignant lymphoma after liver transplantation.

Sánchez-González B, Fernández-Abellán P, Garcia Garay MC, Villarrubia B, Palmero MF, Rivas C.

Bone Marrow Transplant. 2004 May;33(10):1071-2. No abstract available.

PMID:
15034545
13.

Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).

Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E.

Leuk Lymphoma. 2003 Sep;44(9):1541-3. Review.

PMID:
14565657
14.

Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome.

Constans M, Sureda A, Terol MJ, Arranz R, Caballero MD, Iriondo A, Jarque I, Carreras E, Moraleda JM, Carrera D, León A, López A, Albó C, Díaz-Mediavilla J, Fernández-Abellán P, García-Ruiz JC, Hernández-Navarro F, Mataix R, Petit J, Pascual MJ, Rifón J, García-Conde J, Fernández-Rañada JM, Mateos MV, Sierra J, Conde E; GEL/TAMO Cooperative Group.

Ann Oncol. 2003 May;14(5):745-51.

PMID:
12702529
15.

Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.

Oriol A, Ribera JM, Esteve J, Sanz MA, Brunet S, Garcia-Boyero R, Fernández-Abellán P, Martí JM, Abella E, Sánchez-Delgado M, Peñarrubia MJ, Besalduch J, Moreno MJ, Borrego D, Feliu E, Ortega JJ; PETHEMA Group, Spanish Society of Hematology.

Haematologica. 2003 Apr;88(4):445-53.

16.

Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia.

Sanchez-Gonzalez B, Pascual-Ramirez JC, Fernandez-Abellan P, Belinchon-Romero I, Rivas C, Vegara-Aguilera G.

Blood. 2003 Mar 15;101(6):2446. No abstract available.

17.

[Cytomegalovirus enteritis after autologous peripheral blood stem cell transplantation].

Sánchez-González B, Fernández-Abellán P, Rivas C, Villarrubia B.

Med Clin (Barc). 2002 Nov 30;119(19):757. Spanish. No abstract available.

PMID:
12487978
18.

[Hypercoagulation markers in myocardial infarction].

Marín Ortuño F, Fernández Abellán P, Fernández Carballido C, Roldán Shilling V, Marco Vera P.

An Med Interna. 1999 Nov;16(11):601. Spanish. No abstract available.

PMID:
10638005
19.

[Tissue plasminogen activator as a prognostic factor in myocardial infarct patients].

Fernández Abellán P, Marín Ortuño F, Marco Vera P, Luján Martínez J.

Rev Clin Esp. 1999 Apr;199(4):215-7. Spanish.

PMID:
10364793
20.

Acute leukemias after treatment with radioiodine for thyroid cancer.

Roldán Schilling V, Fernández Abellán P, Domínguez Escribano JR, Rivas González C, Mut Barberá E, Calatayud Cendra R.

Haematologica. 1998 Aug;83(8):767-8. Review.

21.

[Diabetes insipidus associated with a refractory anemia].

Fernández Abellán P, Roldán Schilling V, Valencia Valencia P, Domínguez Escribano JR.

Rev Clin Esp. 1996 Sep;196(9):664-5. Spanish. No abstract available.

PMID:
8966333

Supplemental Content

Loading ...
Support Center